Maternal health and pregnancy outcome in diagnosed and undiagnosed Marfan syndrome: A registry-based study

Kristian A Groth, Birgitte B Nielsen, Inger N Sheyanth, Claus H Gravholt, Niels H Andersen*, Kirstine Stochholm


Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


In Marfan syndrome (MFS), pregnancy is considered as high risk due to the deficiency of fibrillin in the connective tissue and increased risk of aortic dissection. The objective was to demonstrate the consequences on maternal health, in women with diagnosed and undiagnosed MFS at the time of pregnancy and childbirth. By using national health care registries, we identified all pregnancy related outcomes, from women with MFS (n = 183) and an age-matched background population (n = 18,300). We found 91 pregnancies during follow-up. Significantly fewer women with MFS gave birth, compared to the background population. No women with known MFS had a pregnancy related aortic dissection but complications related to the cervix were increased (HR:19.8 [95% CI:2.2-177.5]). Fifty women with MFS were undiagnosed at the time of their first pregnancy and/or childbirth. Among these, there were more birth canal related complications HR:27.2 (95% CI: 2.3-315.0), preeclampsia (HR:2.25 [95% CI: 1.11-4.60]), fetal deaths (HR:12.3 [95% CI: 1.51-99.8]), and all delivery-related dissections came from this subgroup. In conclusion, undiagnosed women with MFS experienced more pregnancy and childbirth related complications including fetal death, birth canal issues, preeclampsia, and aortic disease, which emphasizes the need for an early MFS diagnosis and special care during pregnancy and childbirth.

TidsskriftAmerican Journal of Medical Genetics. Part A
Udgave nummer5
Sider (fra-til)1414-1420
Antal sider7
StatusUdgivet - maj 2021


Dyk ned i forskningsemnerne om 'Maternal health and pregnancy outcome in diagnosed and undiagnosed Marfan syndrome: A registry-based study'. Sammen danner de et unikt fingeraftryk.